GlaxoSmithKline rejects Unilever's £50 billion offer for its consumer healthcare business as bidding war intensifies
Shares in pharmaceutical giant GlaxoSmithKline (GSK) shot to the top of the FTSE 100 leaderboard on Monday, gaining 5% to £17.19 after the company revealed it had received three unsolicited offers from Unilever (ULVR) for its...
17 January 2022